BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24119420)

  • 1. [Arterial bypass iterative thrombosis and cancer: three cases].
    Villemur B; Payraud E; Seetha V; De Angelis MP; Magne JL; Perennou D; Carpentier P; Pernod G
    J Mal Vasc; 2014 Feb; 39(1):14-7. PubMed ID: 24119420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of thrombophilic risk factors in patients with arterial thromboses].
    Zotz RB
    Hamostaseologie; 2008; 28(3):120-9. PubMed ID: 18521489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
    Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
    Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
    Za T; De Stefano V; Rossi E; Petrucci MT; Andriani A; Annino L; Cimino G; Caravita T; Pisani F; Ciminello A; Torelli F; Villivà N; Bongarzoni V; Rago A; Betti S; Levi A; Felici S; Gentilini F; Calabrese E; Leone G;
    Br J Haematol; 2013 Mar; 160(5):673-9. PubMed ID: 23240810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors for the development of thrombotic complication in patients with lupus erythematosus and lupus nephropatic].
    Zaldívar-Alcántara H; Herrera-Jiménez LE; Dehesa-López E; Correa-Rotter R
    Rev Invest Clin; 2013; 65(3):199-208. PubMed ID: 23877806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between venous and arterial thrombosis: clinical implications.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Jun; 23(4):333-7. PubMed ID: 22560380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical technique and peripheral artery disease.
    Slovut DP; Lipsitz EC
    Circulation; 2012 Aug; 126(9):1127-38. PubMed ID: 22927475
    [No Abstract]   [Full Text] [Related]  

  • 11. Ischemic peripheral arterial disease and recurrent iliofemoral venous thrombosis in a 24-year-old man with antiphospholipid syndrome.
    Ručka D; Bojanovská K; Heller S; Procházka P; Skalická L; Vařejka P; Chochola M; Linhart A; Karetová D
    Vnitr Lek; 2013 Feb; 59(2):127-31. PubMed ID: 23461402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings.
    Provenzale JM; Ortel TL
    AJR Am J Roentgenol; 1995 Aug; 165(2):365-8. PubMed ID: 7618558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and arterial disease. An up-to-date review of the literature for the vascular surgeon.
    Böhm G; Al-Khaffaf H
    Int Angiol; 2003 Jun; 22(2):116-24. PubMed ID: 12865876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of thrombosis in the antiphospholipid-antibody syndrome.
    Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
    N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients].
    Gillet JL; Perrin M; Cayman R
    J Mal Vasc; 2001 Feb; 26(1):16-22. PubMed ID: 11240525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
    Sallah S; Wan JY; Nguyen NP
    Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent ischemia in a young man with the antiphospholipid syndrome.
    Best IM; Vansandani G; Rust G; Bumpers HL
    Am Surg; 2002 Jul; 68(7):598-602. PubMed ID: 12132740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What vascular events suggest a myeloproliferative disorder?].
    Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
    J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.